7PO5 image
Entry Detail
PDB ID:
7PO5
EMDB ID:
Keywords:
Title:
Human coronavirus OC43 spike glycoprotein ectodomain in complex with the 47C9 antibody Fab fragment
Biological Source:
Host Organism:
PDB Version:
Deposition Date:
2021-09-08
Release Date:
2022-04-20
Method Details:
Experimental Method:
Resolution:
3.90 Å
Aggregation State:
PARTICLE
Reconstruction Method:
SINGLE PARTICLE
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:Spike glycoprotein
Chain IDs:C (auth: B), F (auth: C), I (auth: A)
Chain Length:1322
Number of Molecules:3
Biological Source:Human coronavirus OC43
Polymer Type:polypeptide(L)
Description:47C9 antibody light chain
Chain IDs:B (auth: D), E (auth: F), H (auth: L)
Chain Length:107
Number of Molecules:3
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Description:47C9 antibody heavy chain
Chain IDs:A (auth: Z), D (auth: X), G (auth: H)
Chain Length:124
Number of Molecules:3
Biological Source:Homo sapiens
Ligand Molecules
Primary Citation
Antigenic structure of the human coronavirus OC43 spike reveals exposed and occluded neutralizing epitopes.
Nat Commun 13 2921 2921 (2022)
PMID: 35614127 DOI: 10.1038/s41467-022-30658-0

Abstact

Human coronavirus OC43 is a globally circulating common cold virus sustained by recurrent reinfections. How it persists in the population and defies existing herd immunity is unknown. Here we focus on viral glycoprotein S, the target for neutralizing antibodies, and provide an in-depth analysis of its antigenic structure. Neutralizing antibodies are directed to the sialoglycan-receptor binding site in S1A domain, but, remarkably, also to S1B. The latter block infection yet do not prevent sialoglycan binding. While two distinct neutralizing S1B epitopes are readily accessible in the prefusion S trimer, other sites are occluded such that their accessibility must be subject to conformational changes in S during cell-entry. While non-neutralizing antibodies were broadly reactive against a collection of natural OC43 variants, neutralizing antibodies generally displayed restricted binding breadth. Our data provide a structure-based understanding of protective immunity and adaptive evolution for this endemic coronavirus which emerged in humans long before SARS-CoV-2.

Legend

Protein

Chemical

Disease

Primary Citation of related structures